Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Sun, July 19, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009
Mon, July 13, 2009
Fri, July 10, 2009
Thu, July 9, 2009
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009
Mon, June 29, 2009
Fri, June 26, 2009
Thu, June 25, 2009
Wed, June 24, 2009
Tue, June 23, 2009
Mon, June 22, 2009
Sun, June 21, 2009
Fri, June 19, 2009
Thu, June 18, 2009
Wed, June 17, 2009
Tue, June 16, 2009
Mon, June 15, 2009
Fri, June 12, 2009
Thu, June 11, 2009
Wed, June 10, 2009
Tue, June 9, 2009
Mon, June 8, 2009
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009
Mon, June 1, 2009
Sat, May 30, 2009
Fri, May 29, 2009
Thu, May 28, 2009
Wed, May 27, 2009
Tue, May 26, 2009
Mon, May 25, 2009
Fri, May 22, 2009
Thu, May 21, 2009
Wed, May 20, 2009
Tue, May 19, 2009
Mon, May 18, 2009
Fri, May 15, 2009
Thu, May 14, 2009
Wed, May 13, 2009
Tue, May 12, 2009

Vanguard Pharmaceutical Corp.: Vanguard Pharmaceutical Corporation Has Acquired a Natural Flu Remedy -- Swine Guard


//health-fitness.news-articles.net/content/2009/ .. s-acquired-a-natural-flu-remedy-swine-guard.html
Published in Health and Fitness on Monday, June 15th 2009 at 9:01 GMT, Last Modified on 2009-06-15 09:03:13 by Market Wire   Print publication without navigation


SAN ANTONIO, TX--(Marketwire - June 15, 2009) - Vanguard Pharmaceutical Corporation (PINKSHEETS: [ VGPH ]) has recently acquired a naturally derived product formulated to aid against strains of influenza by strengthening the immune system. Their unique formula combines traditional Chinese medicine with many extracts that have proven to boost the immune system as well as offer many other benefits in the fight against influenza. Swine Guard is formulated with:

 -- Shikimic Acid a traditional Chinese medicine to treat influenza and colds by strengthening the immune system and by functioning as an anti- inflammatory. -- Echinacea Purpurea Extract stimulates the immune system, prevents upper respiratory tract infections, is a mild antibiotic that fights strep and staph infections, and produces interferon which increases antiviral activity by improving the migration of white blood cells to attack foreign microorganisms and toxins in the bloodstream. -- Microcrystalline Cellulose fortifies blood vessels, aids in the repair and maintenance of vital lungs, and improves the lymphatic system. -- Ascorbic Acid an antioxidant that enhances the immune system, helps regenerate wounds, protects against effects of stress, and helps prevent certain cancers. -- Goldenseal Root Extract enhances the immune function, relieves stress, is an energy boost and improves the libido. -- Burdock Root purifies the liver, neutralizes most poisons, and detoxifies the system. -- Licorice Root Extract treats sore throats and rejuvenates cells of the digestive system and liver. -- Shaitake Mushroom, Astragulus Root Extract, and Pau D'Arce Extract, all work to enhance the immune function. 

Vanguard Pharmaceutical believes prevention is the key to fighting influenza. With the World Health Organization recently declaring a swine flu pandemic, it is our responsibility to prevent the spread by taking the necessary precautions.

[ www.vanguardpharm.com ]

About Vanguard Pharmaceutical

In an era of ageing populations, rising health care costs, and increasing cancer cases Vanguard's mission is to decrease health care expenditures by selling affordable oncology and generic drugs and by investing in research to find a noninvasive cure for cancer.

Generic medicines allow patients to access safe, effective, high-quality medicines at 10%-80% of the price of branded originator medicines. In this way, generic medicines support the sustainability of health care provision and contribute to controlling pharmaceutical expenditure. Vanguard is currently targeting Latin America for its oncology and generic pharmaceutical sales as it is believed to have a substantially unmet demand for advanced generics and entry into the market can be done with relative ease. Latin America is set to emerge as a globally significant market and its generics market is conservatively expected to reach US$6.4 billion by the year-end of 2009.

A noninvasive cure for cancer will revolutionize our health care system by highly reducing hospital stays as patients will not have to go through life threatening chemotherapy and radiation which could save health care systems billions of dollars. Vanguard's team is researching several new technologies such as telomerase inhibitor therapy, nanoparticle therapies, and low power radio frequency radiation. Vanguard plans to partner with established clinical centers and universities to further develop these technologies then license them out. It has also discussed performing trials in Latin American oncology centers.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.


Publication Contributing Sources

Similar Health and Fitness Publications